Autocrine IGF2 programmes β-cell plasticity under conditions of increased metabolic demand.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 04 2021
Historique:
received: 17 12 2020
accepted: 08 03 2021
entrez: 9 4 2021
pubmed: 10 4 2021
medline: 9 11 2021
Statut: epublish

Résumé

When exposed to nutrient excess and insulin resistance, pancreatic β-cells undergo adaptive changes in order to maintain glucose homeostasis. The role that growth control genes, highly expressed in early pancreas development, might exert in programming β-cell plasticity in later life is a poorly studied area. The imprinted Igf2 (insulin-like growth factor 2) gene is highly transcribed during early life and has been identified in recent genome-wide association studies as a type 2 diabetes susceptibility gene in humans. Hence, here we investigate the long-term phenotypic metabolic consequences of conditional Igf2 deletion in pancreatic β-cells (Igf2

Identifiants

pubmed: 33833312
doi: 10.1038/s41598-021-87292-x
pii: 10.1038/s41598-021-87292-x
pmc: PMC8032793
doi:

Substances chimiques

IGF2 protein, mouse 0
Insulin 0
Insulin-Like Growth Factor II 67763-97-7
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7717

Subventions

Organisme : Medical Research Council
ID : MC_UU_12012/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/2
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/H003312/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRC 979241
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRC_MC_UU_12012/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRC_MC_UU_12012/5
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRC_MC_UU_00014/4
Pays : United Kingdom

Références

Gene. 2014 Jan 1;533(1):434-8
pubmed: 24125951
Diabetes Res Clin Pract. 2008 Apr;80(1):8-15
pubmed: 18291552
Cell Metab. 2013 Jul 2;18(1):9-20
pubmed: 23823474
Nature. 1990 May 3;345(6270):78-80
pubmed: 2330056
PLoS Biol. 2020 Feb 24;18(2):e3000603
pubmed: 32092075
BMC Dev Biol. 2001;1:4
pubmed: 11299042
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Diabetes. 2015 Dec;64(12):4148-57
pubmed: 26384384
Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):13-25
pubmed: 11921414
J Proteomics. 2012 Aug 3;75(15):4620-31
pubmed: 22569486
J Clin Invest. 2019 Oct 1;129(10):4001-4008
pubmed: 31424428
Diabetologia. 2015 Mar;58(3):558-65
pubmed: 25500700
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6181-6
pubmed: 23530192
Obesity (Silver Spring). 2007 Apr;15(4):798-808
pubmed: 17426312
Trends Endocrinol Metab. 2010 Mar;21(3):151-8
pubmed: 20015659
Mol Endocrinol. 2009 Jun;23(6):747-58
pubmed: 19196831
J Biol Chem. 2020 Dec 4;295(49):16510-16528
pubmed: 32934005
Cell Mol Life Sci. 2013 May;70(9):1575-95
pubmed: 23463236
Adv Exp Med Biol. 2010;654:463-77
pubmed: 20217510
Diabetologia. 2016 Apr;59(4):734-43
pubmed: 26762333
J Biol Chem. 2015 Aug 7;290(32):19955-66
pubmed: 26109062
Curr Diab Rep. 2017 Apr;17(4):22
pubmed: 28293907
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1986-1991
pubmed: 29223399
Diabetes Care. 2001 Apr;24(4):659-62
pubmed: 11315827
Int J Body Compos Res. 2009;7(4):147-154
pubmed: 21909234
Exp Anim. 1997 Jan;46(1):75-8
pubmed: 9027475
Endocrinology. 1999 May;140(5):2353-63
pubmed: 10218989
Trends Endocrinol Metab. 2000 Nov;11(9):375-8
pubmed: 11042468
Development. 2000 Jun;127(11):2317-22
pubmed: 10804174
Endocr J. 2009;56(1):113-20
pubmed: 18946176
Cell Transplant. 2012;21(10):2119-29
pubmed: 22507193
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Mol Metab. 2018 Sep;15:82-91
pubmed: 29891438
Cell Metab. 2014 Dec 2;20(6):979-90
pubmed: 25470546
J Clin Invest. 2000 Mar;105(6):731-40
pubmed: 10727441
Nat Rev Endocrinol. 2012 Feb 14;8(6):342-51
pubmed: 22330739
PLoS Genet. 2007 Apr 27;3(4):e64
pubmed: 17465682
Biosci Rep. 2020 Feb 28;40(2):
pubmed: 32003782
Diabetologia. 1978 Nov;15(5):387-93
pubmed: 738549
Methods Mol Biol. 2009;560:221-38
pubmed: 19504253
PLoS One. 2008 Feb 27;3(2):e1668
pubmed: 18301746
J Endocrinol. 2009 Oct;203(1):55-63
pubmed: 19592596
Reprod Biomed Online. 2012 Jul;25(1):68-89
pubmed: 22560117
Nature. 2016 Oct 13;538(7624):248-252
pubmed: 27680694
Front Physiol. 2018 Aug 17;9:1091
pubmed: 30174608
Nature. 1994 Dec 1;372(6505):425-32
pubmed: 7984236
J Biol Chem. 2018 Mar 23;293(12):4324-4333
pubmed: 29414792
J Biol Chem. 2013 Oct 4;288(40):29013-23
pubmed: 23935095
Cell. 1991 Feb 22;64(4):849-59
pubmed: 1997210
Diabetes. 2010 Dec;59(12):3090-8
pubmed: 20802254
Genome Res. 2013 Sep;23(9):1554-62
pubmed: 23716500
Hum Mol Genet. 2015 Mar 1;24(5):1390-9
pubmed: 25355422
Am J Physiol Endocrinol Metab. 2014 Nov 15;307(10):E906-18
pubmed: 25249504
Diabetes. 2016 Jun;65(6):1648-59
pubmed: 26953164
J Clin Invest. 2006 Jul;116(7):1802-12
pubmed: 16823478
BJOG. 2008 Jan;115(2):253-9; discussion 260
pubmed: 18081603
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2415-20
pubmed: 18272492
Diabetes. 2017 Nov;66(11):2903-2914
pubmed: 28838971
Endocr Relat Cancer. 2009 Sep;16(3):939-52
pubmed: 19502451
Cell Metab. 2017 May 2;25(5):1194-1205.e4
pubmed: 28467935
Genes Dev. 2011 Jun 1;25(11):1159-72
pubmed: 21576258
Endocrinology. 1998 Jun;139(6):2994-3004
pubmed: 9607811
Am J Physiol Endocrinol Metab. 2018 Mar 1;314(3):E251-E265
pubmed: 29118016
PLoS Genet. 2020 Oct 15;16(10):e1009069
pubmed: 33057429
Diabetes. 2009 Aug;58(8):1816-25
pubmed: 19401425
Aging (Albany NY). 2011 Jun;3(6):565-75
pubmed: 21765202
Diabetologia. 2007 Jul;50(7):1463-71
pubmed: 17476475
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5137-40
pubmed: 9144203
Science. 2007 Jun 1;316(5829):1336-41
pubmed: 17463249

Auteurs

Ionel Sandovici (I)

Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK. is299@cam.ac.uk.
Department of Obstetrics and Gynaecology and National Institute for Health Research, Cambridge Biomedical Research Centre, Cambridge, CB2 0SW, UK. is299@cam.ac.uk.
Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, CB2 3EG, UK. is299@cam.ac.uk.

Constanze M Hammerle (CM)

Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK. czmh@novonordisk.com.
Department of Obstetrics and Gynaecology and National Institute for Health Research, Cambridge Biomedical Research Centre, Cambridge, CB2 0SW, UK. czmh@novonordisk.com.
Novo Nordisk A/S, 2880, Bagsværd, Denmark. czmh@novonordisk.com.

Sam Virtue (S)

Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK.

Yurena Vivas-Garcia (Y)

Área de Bioquímica y Biología Molecular, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, 28922, Alcorcón, Madrid, Spain.
Nuffield Department of Clinical Medicine, Ludwig Institute for Cancer Research, University of Oxford, Headington, Oxford, OX3 7DQ, UK.

Adriana Izquierdo-Lahuerta (A)

Área de Bioquímica y Biología Molecular, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, 28922, Alcorcón, Madrid, Spain.

Susan E Ozanne (SE)

Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK.

Antonio Vidal-Puig (A)

Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK.
Welcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.
Cambridge University Nanjing Centre of Technology and Innovation, Jiangbei Area, Nanjing, People's Republic of China.

Gema Medina-Gómez (G)

Área de Bioquímica y Biología Molecular, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, 28922, Alcorcón, Madrid, Spain.

Miguel Constância (M)

Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK. jmasmc2@cam.ac.uk.
Department of Obstetrics and Gynaecology and National Institute for Health Research, Cambridge Biomedical Research Centre, Cambridge, CB2 0SW, UK. jmasmc2@cam.ac.uk.
Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, CB2 3EG, UK. jmasmc2@cam.ac.uk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH